Tech Company Financing Transactions
Erbi Biosystems Funding Round
Jaguar Biotech and private investors participated in a $3.8 million funding round for Erbi Biosystems. The round was recorded on 11/3/2020.
Transaction Overview
Company Name
Announced On
11/3/2020
Transaction Type
Venture Equity
Amount
$3,800,000
Round
Undisclosed
Investors
Jaguar Biotech (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand manufacturing, sales and support of its existing 2mL, TruePerfusion Breez bioreactor, while also further develop its technology platform and product pipeline.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
325 New Boston St. 6
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Undisclosed
Website
Email Address
Overview
Through microfluidic technology and integration, we at Erbi Biosystems have miniaturized large scale bioreactors to the milliliter scale. This technology enables control and parallelization, as well as greatly reducing the labor and space required by systems with traditional culturing systems.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Chiu
VP - Product Management
Kathie Schneider
Browse more venture capital transactions:
Prev: 11/3/2020: MOMI Brands venture capital transaction
Next: 11/3/2020: Stensul venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC transactions on this site are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs